You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (42) |
Back to Search
Cost-Effectiveness of Rivaroxaban versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation in the Guangdong Healthcare Setting in China
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-E-043-Tuesday
- By: ZHOU, Jing (guangzhou, China)
- Co-author(s): Jing Zhou: Department of Pharmacy, Guangdong General Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China
Biyu Huang: Department of Pharmacy, Guangdong General Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China
Min Yang: Department of Pharmacy, Guangdong General Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China - Abstract:
Backgrounds
Warfarin has been the mainstay of anticoagulant therapy for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). Rivaroxaban, a novel oral anticoagulant which offers some distinct advantages over warfarin has been introduced.Aims
To evaluate the cost-effectiveness of rivaroxaban versus warfarin for stroke prevention .. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026